XIX International AIDS Conference

Cobicistat versus ritonavir as pharmacoenhancers in combination with atazanavir plus tenofovir disoproxil fumarate/emtricitabine: phase 3 randomized, double blind, active-controlled trial, week 48 results TUAB0103

Time: 11:35
Speaker: Joel Gallant

This text willreplaced

You can download the video file here

For more information on this presentation, including access to speaker presentations, please see the conference Programme-at-a-Glance page.

Contact Us | Site map © 2012 International AIDS Society